+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Topical Scar Treatment Market Size, Share & Trends Analysis Report By End-use, By Scar Type (Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks), By Product, By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 118 Pages
  • March 2024
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5949407
The Asia Pacific Topical Scar Treatment Market would witness market growth of 10.1% CAGR during the forecast period (2023-2030).

The China market dominated the Asia Pacific Topical Scar Treatment Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,213.9 million by 2030. The Japan market is registering a CAGR of 9.3% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 10.8% during (2023 - 2030).



Topical scar treatments often contain ingredients that target pigmentation issues associated with scars, helping to reduce redness, hyperpigmentation, or hypopigmentation. Scar treatments may contain ingredients such as silicone, which can help improve the texture of scars by hydrating the skin and creating a smoother surface. Consumers have been increasingly seeking products with natural and organic ingredients.

The industry has seen continuous efforts to develop advanced formulations that offer improved efficacy in scar reduction. This includes innovations in delivery systems, such as gels, creams, and patches, designed to enhance the absorption of active ingredients. Consumers often prefer non-invasive or minimally invasive treatments. This trend extends to scar treatments, with topical solutions more popular than surgical or invasive procedures for certain scars.

Rising disposable income allows individuals in India to allocate funds for personal care and cosmetic products. The growing disposable income levels increase the willingness to invest in personal care and appearance in India. Higher disposable income allows consumers in India to explore and purchase various products. With higher disposable incomes, consumers in India are becoming more conscious of skincare. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.

Based on End-use, the market is segmented into Hospitals, Clinics, and Homecare. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on Product, the market is segmented into Creams, Gels, Silicon Sheets, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

  • Smith & Nephew PLC
  • Lumenis Be Ltd.
  • Merz Pharma GmbH & Co. KGaA
  • Sonoma Pharmaceuticals Inc.
  • Molnlycke Health Care AB
  • Suneva Medical, Inc.
  • Perrigo Company PLC
  • Cynosure, LLC
  • Newmedical Technology Inc.
  • Integra LifeSciences Holdings Corporation

Market Report Segmentation

By End-use
  • Hospitals
  • Clinics
  • Homecare
By Scar Type
  • Atrophic Scars
  • Hypertrophic & Keloid Scars
  • Contracture Scars
  • Stretch Marks
By Product
  • Creams
  • Gels
  • Silicon Sheets
  • Others
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Topical Scar Treatment Market, by End-use
1.4.2 Asia Pacific Topical Scar Treatment Market, by Scar Type
1.4.3 Asia Pacific Topical Scar Treatment Market, by Product
1.4.4 Asia Pacific Topical Scar Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Asia Pacific Topical Scar Treatment Market by End-use
4.1 Asia Pacific Hospitals Market by Country
4.2 Asia Pacific Clinics Market by Country
4.3 Asia Pacific Homecare Market by Country
Chapter 5. Asia Pacific Topical Scar Treatment Market by Scar Type
5.1 Asia Pacific Atrophic Scars Market by Country
5.2 Asia Pacific Hypertrophic & Keloid Scars Market by Country
5.3 Asia Pacific Contracture Scars Market by Country
5.4 Asia Pacific Stretch Marks Market by Country
Chapter 6. Asia Pacific Topical Scar Treatment Market by Product
6.1 Asia Pacific Creams Market by Country
6.2 Asia Pacific Gels Market by Country
6.3 Asia Pacific Silicon Sheets Market by Country
6.4 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Topical Scar Treatment Market by Country
7.1 China Topical Scar Treatment Market
7.1.1 China Topical Scar Treatment Market by End-use
7.1.2 China Topical Scar Treatment Market by Scar Type
7.1.3 China Topical Scar Treatment Market by Product
7.2 Japan Topical Scar Treatment Market
7.2.1 Japan Topical Scar Treatment Market by End-use
7.2.2 Japan Topical Scar Treatment Market by Scar Type
7.2.3 Japan Topical Scar Treatment Market by Product
7.3 India Topical Scar Treatment Market
7.3.1 India Topical Scar Treatment Market by End-use
7.3.2 India Topical Scar Treatment Market by Scar Type
7.3.3 India Topical Scar Treatment Market by Product
7.4 South Korea Topical Scar Treatment Market
7.4.1 South Korea Topical Scar Treatment Market by End-use
7.4.2 South Korea Topical Scar Treatment Market by Scar Type
7.4.3 South Korea Topical Scar Treatment Market by Product
7.5 Singapore Topical Scar Treatment Market
7.5.1 Singapore Topical Scar Treatment Market by End-use
7.5.2 Singapore Topical Scar Treatment Market by Scar Type
7.5.3 Singapore Topical Scar Treatment Market by Product
7.6 Malaysia Topical Scar Treatment Market
7.6.1 Malaysia Topical Scar Treatment Market by End-use
7.6.2 Malaysia Topical Scar Treatment Market by Scar Type
7.6.3 Malaysia Topical Scar Treatment Market by Product
7.7 Rest of Asia Pacific Topical Scar Treatment Market
7.7.1 Rest of Asia Pacific Topical Scar Treatment Market by End-use
7.7.2 Rest of Asia Pacific Topical Scar Treatment Market by Scar Type
7.7.3 Rest of Asia Pacific Topical Scar Treatment Market by Product
Chapter 8. Company Profiles
8.1 Smith & Nephew PLC
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional and Segmental Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Lumenis Be Ltd.
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.2.2.2 Product Launches and Product Expansions:
8.2.3 SWOT Analysis
8.3 Merz Pharma GmbH & Co. KGaA
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.3 SWOT Analysis
8.4 Sonoma Pharmaceuticals, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.6 SWOT Analysis
8.5 Molnlycke Health Care AB
8.5.1 Company Overview
8.5.2 SWOT Analysis
8.6 Suneva Medical, Inc.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Product Launches and Product Expansions:
8.6.3 SWOT Analysis
8.7 Perrigo Company PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.8.3 SWOT Analysis
8.9 Newmedical Technology Inc.
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Integra LifeSciences Holdings Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis

Companies Mentioned

  • Smith & Nephew PLC
  • Lumenis Be Ltd.
  • Merz Pharma GmbH & Co. KGaA
  • Sonoma Pharmaceuticals Inc.
  • Molnlycke Health Care AB
  • Suneva Medical, Inc.
  • Perrigo Company PLC
  • Cynosure, LLC
  • Newmedical Technology Inc.
  • Integra LifeSciences Holdings Corporation

Methodology

Loading
LOADING...